Additional Co-Developed Products. In lieu of the payments to be made by Xxxxxx pursuant to Section 6.4.1(b), to the extent that one (1) or more Co-Developed Products are Developed and Commercialized following receipt of Commercialization Regulatory Approval of the first Product, regardless of whether the first Product is an Initial Product or an Initial Co-Developed Product, Xxxxxx shall make each of the following non-refundable, non-creditable payments to Enanta within thirty (30) days after the occurrence of each of the following milestone events for each additional Co-Developed Product (each, an “Additional Co-Developed Product”): [*****] [*****] [*****] [*****]
Appears in 3 contracts
Samples: Development and License Agreement (Enanta Pharmaceuticals Inc), License Agreement, Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc)
Additional Co-Developed Products. In lieu of the payments to be made by Xxxxxx pursuant to Section 6.4.1(b), to the extent that one (1) or more Co-Developed Products are Developed and Commercialized following receipt of Commercialization Regulatory Approval of the first Product, regardless of whether the first Product is an Initial Product or an Initial Co-Developed Product, Xxxxxx shall make each of the following non-refundable, non-creditable payments to Enanta within thirty (30) days after the occurrence of each of the following milestone events for each additional Co-Developed Product (each, an “Additional Co-Developed Product”): [*****] [****** ] [*****] [****** ]
Appears in 3 contracts
Samples: Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc), Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc), Collaborative Development and License Agreement (Enanta Pharmaceuticals Inc)